“ Pharmacovigilance in oncology: pattern of spontaneous notifications, incidence of adverse drug reactions and under-reporting ”, Braz. J. Pharm. Sci., vol. 50, no. 2, pp. 411–422, Apr. 2014, doi: 10.1590/S1984-82502014000200021.